Bayer Zydus Pharma

Bayer Zydus Pharma is a joint venture between the German pharmaceutical giant Bayer and the Indian global life sciences company Zydus Lifesciences. Established in 2011, the company focuses on the marketing and sales of innovative pharmaceutical products within the Indian market. Its core therapeutic areas include women's healthcare, cardiology, oncology, metabolic disorders, and diagnostic imaging. By leveraging Bayer's global research pipeline and Zydus's extensive distribution network in India, the entity provides advanced medical solutions to patients across the subcontinent. Key products in its portfolio include Xarelto, Eylea, and Kerendia. The partnership combines international R&D excellence with deep local market insights to improve healthcare access in India.